136 related articles for article (PubMed ID: 826854)
1. [Results of therapy in Hodgkin's disease with special reference to polychemotherapy (MOPP)].
Büchi G; Cervellera M; Vigna-Taglianti G; Denna V; Navone R
Minerva Med; 1976 Dec; 67(59):3913-20. PubMed ID: 826854
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of Hodgkin's disease: review of 90 cases].
Büchi G; Mazza U; Saglio G; Rolfo F; Cappio FC; Vighetto AM; Guerrasio A
Arch Sci Med (Torino); 1979; 136(2):295-302. PubMed ID: 518282
[TBL] [Abstract][Full Text] [Related]
3. [Comments about use of polychemotherapy MOPP associated with radiotherapy in the treatment of early stages of Hodgkin's disease. Preliminary report of 58 patients (author's transl)].
Brun B; Alaoui Y; Kuentz M; Baillet F; Maylin C; Vernant JP; Reyes F; Rochant H; Pierquin B; Dreyfus B
Ann Med Interne (Paris); 1980; 131(4):239-43. PubMed ID: 7425449
[TBL] [Abstract][Full Text] [Related]
4. [Hodgkin's disease in children. Stage IV. Treatment and results].
Behar C; Gout-Lemerle M; Sarrazin D; Gerard-Marchant R; Raybaut C
Arch Fr Pediatr; 1976; 33(6):527-36. PubMed ID: 949219
[TBL] [Abstract][Full Text] [Related]
5. [The management of Hodgkin's disease with chemotherapy or combined modality treatment].
Tsushita K; Utsumi M; Shimoyama M
Gan To Kagaku Ryoho; 1998 Dec; 25(14):2202-9. PubMed ID: 9881076
[TBL] [Abstract][Full Text] [Related]
6. Cyclic delivery of MOPP and ABVD combinations in Stage IV Hodgkin's disease: rationale, background studies, and recent results.
Bonadonna G; Santoro A; Bonfante V; Valagussa P
Cancer Treat Rep; 1982 Apr; 66(4):881-7. PubMed ID: 6176323
[TBL] [Abstract][Full Text] [Related]
7. [The role of radiotherapy in the treatment of Hodgkin's disease].
Saito Y; Hirose J; Chohtoh S; Nishijima H; Kobayashi A; Kamimura R; Takashima T; Ohtake S; Yoshida T; Nakamura S
Gan No Rinsho; 1985 Dec; 31(15):1899-904. PubMed ID: 3841562
[TBL] [Abstract][Full Text] [Related]
8. The effect of chemotherapy (MOPP) following radiotherapy in stage I to III Hodgkin's disease: analysis of 110 cases.
Tura S; Lauria F; Baccarani M; Fiacchini M; Frezza R; Mazza P; Babini L; Sciascia R; Emiliani E; Barbieri E
Haematologica; 1979 Feb; 64(1):50-60. PubMed ID: 109365
[No Abstract] [Full Text] [Related]
9. Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study.
Salloum E; Doria R; Farber LR; Roberts KB; Cooper DL
Cancer J Sci Am; 1995; 1(4):267-73. PubMed ID: 9166487
[TBL] [Abstract][Full Text] [Related]
10. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
Mjaaland I; Ganser D; Freitag EM; Bohndorf W
Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy of advanced malignant lymphomas comparative evaluation of results with single agent and combination therapy.
Klener P; Donner L; Roth Z
Neoplasma; 1976; 23(3):315-22. PubMed ID: 958533
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy and combined modality therapy for Hodgkin's disease: a progress report on Cancer and Leukemia Group B studies.
Bloomfield CD; Pajak TF; Glicksman AS; Gottlieb AJ; Coleman M; Nissen NI; Rafla S; Stutzman L; Vinciguerra V; Glidewell OJ; Holland JF
Cancer Treat Rep; 1982 Apr; 66(4):835-46. PubMed ID: 6176320
[TBL] [Abstract][Full Text] [Related]
13. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
14. [Comparative evaluation of the efficacy of chemotherapy and chemoradiotherapy of stage IIIB Hodgkin's disease].
Kanaev SV; Gershanovich ML; Malinin AP; Kholin AV
Vopr Onkol; 1988; 34(4):438-45. PubMed ID: 3376456
[TBL] [Abstract][Full Text] [Related]
15. Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patients.
Brice P; Bastion Y; Divine M; Nedellec G; Ferrant A; Gabarre J; Reman O; Lepage E; Fermé C
Cancer; 1996 Sep; 78(6):1293-9. PubMed ID: 8826953
[TBL] [Abstract][Full Text] [Related]
16. [Questions and aspects of radiotherapy of adult patients with localized supradiaphragmatic stage (CS I/II) Hodgkin's disease. 1. Questions and aspects on indications for primary and adjuvant radiotherapy].
Glanzmann C; Lütolf UM
Strahlenther Onkol; 1993 Aug; 169(8):449-58. PubMed ID: 8356505
[TBL] [Abstract][Full Text] [Related]
17. Multidisciplinary treatment of advanced Hodgkin's disease by an alternating chemotherapeutic regimen of MOPP/ABDV and low-dose radiation therapy restricted to originally bulky disease.
Young CW; Straus DJ; Myers J; Passe S; Nisce LZ; Lee BJ; Koziner B; Arlin Z; Kempin S; Gee T; Clarkson BD
Cancer Treat Rep; 1982 Apr; 66(4):907-14. PubMed ID: 7042090
[TBL] [Abstract][Full Text] [Related]
18. Mitoxantrone, vinblastine, and lomustine (CCNU) (MVC): a highly active regimen for advanced and poor-prognosis Hodgkin's disease.
Wiernik PH; Dutcher JP; Einzig AI; Sparano J; Frank M; Friedenberg W
Cancer J Sci Am; 1998; 4(4):254-60. PubMed ID: 9689984
[TBL] [Abstract][Full Text] [Related]
19. [Radiotherapy instead of second-line chemotherapy in patients with Hodgkin's disease in partial remission after treatment with cytostatics].
Płuzańska A; Dowgier-Witczak I; Chmielowska E; Studencki E; Jedrzejczyk S
Acta Haematol Pol; 1989; 20(2):176-82. PubMed ID: 2638536
[TBL] [Abstract][Full Text] [Related]
20. The therapy of Hodgkin's disease in Nigeria: a five year study.
Oluboyede OA; Esan GJ
Afr J Med Med Sci; 1976 Sep; 5(3):201-7. PubMed ID: 829730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
